These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 17999929

  • 1. Structural insights into the design of inhibitors for the L1 metallo-beta-lactamase from Stenotrophomonas maltophilia.
    Nauton L, Kahn R, Garau G, Hernandez JF, Dideberg O.
    J Mol Biol; 2008 Jan 04; 375(1):257-69. PubMed ID: 17999929
    [Abstract] [Full Text] [Related]

  • 2. Antibiotic binding to dizinc beta-lactamase L1 from Stenotrophomonas maltophilia: SCC-DFTB/CHARMM and DFT studies.
    Xu D, Guo H, Cui Q.
    J Phys Chem A; 2007 Jul 05; 111(26):5630-6. PubMed ID: 17388313
    [Abstract] [Full Text] [Related]

  • 3. Crystal structure of extended-spectrum beta-lactamase Toho-1: insights into the molecular mechanism for catalytic reaction and substrate specificity expansion.
    Ibuka AS, Ishii Y, Galleni M, Ishiguro M, Yamaguchi K, Frère JM, Matsuzawa H, Sakai H.
    Biochemistry; 2003 Sep 16; 42(36):10634-43. PubMed ID: 12962487
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Structural and biochemical analysis of the metallo-β-lactamase L1 from emerging pathogen Stenotrophomonas maltophilia revealed the subtle but distinct di-metal scaffold for catalytic activity.
    Kim Y, Maltseva N, Wilamowski M, Tesar C, Endres M, Joachimiak A.
    Protein Sci; 2020 Mar 16; 29(3):723-743. PubMed ID: 31846104
    [Abstract] [Full Text] [Related]

  • 7. A specific peptide inhibitor of the class B metallo-beta-lactamase L-1 from Stenotrophomonas maltophilia identified using phage display.
    Sanschagrin F, Levesque RC.
    J Antimicrob Chemother; 2005 Feb 16; 55(2):252-5. PubMed ID: 15659541
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Structure and dynamics of CTX-M enzymes reveal insights into substrate accommodation by extended-spectrum beta-lactamases.
    Delmas J, Chen Y, Prati F, Robin F, Shoichet BK, Bonnet R.
    J Mol Biol; 2008 Jan 04; 375(1):192-201. PubMed ID: 17999931
    [Abstract] [Full Text] [Related]

  • 12. Noncovalent interaction energies in covalent complexes: TEM-1 beta-lactamase and beta-lactams.
    Wang X, Minasov G, Shoichet BK.
    Proteins; 2002 Apr 01; 47(1):86-96. PubMed ID: 11870868
    [Abstract] [Full Text] [Related]

  • 13. Thermodynamic cycle analysis and inhibitor design against beta-lactamase.
    Roth TA, Minasov G, Morandi S, Prati F, Shoichet BK.
    Biochemistry; 2003 Dec 16; 42(49):14483-91. PubMed ID: 14661960
    [Abstract] [Full Text] [Related]

  • 14. Antibiotic deactivation by a dizinc beta-lactamase: mechanistic insights from QM/MM and DFT studies.
    Xu D, Guo H, Cui Q.
    J Am Chem Soc; 2007 Sep 05; 129(35):10814-22. PubMed ID: 17691780
    [Abstract] [Full Text] [Related]

  • 15. Force field design and molecular dynamics simulations of the carbapenem- and cephamycin-resistant dinuclear zinc metallo-beta-lactamase from Bacteroides fragilis and its complex with a biphenyl tetrazole inhibitor.
    Park H, Merz KM.
    J Med Chem; 2005 Mar 10; 48(5):1630-7. PubMed ID: 15743204
    [Abstract] [Full Text] [Related]

  • 16. Crystal structures of the class D beta-lactamase OXA-13 in the native form and in complex with meropenem.
    Pernot L, Frénois F, Rybkine T, L'Hermite G, Petrella S, Delettré J, Jarlier V, Collatz E, Sougakoff W.
    J Mol Biol; 2001 Jul 20; 310(4):859-74. PubMed ID: 11453693
    [Abstract] [Full Text] [Related]

  • 17. Design of new benzoxazole-2-thione-derived inhibitors of Streptococcus pneumoniae hyaluronan lyase: structure of a complex with a 2-phenylindole.
    Rigden DJ, Botzki A, Nukui M, Mewbourne RB, Lamani E, Braun S, von Angerer E, Bernhardt G, Dove S, Buschauer A, Jedrzejas MJ.
    Glycobiology; 2006 Aug 20; 16(8):757-65. PubMed ID: 16638841
    [Abstract] [Full Text] [Related]

  • 18. 4-Substituted trinems as broad spectrum beta-lactamase inhibitors: structure-based design, synthesis, and biological activity.
    Plantan I, Selic L, Mesar T, Anderluh PS, Oblak M, Prezelj A, Hesse L, Andrejasic M, Vilar M, Turk D, Kocijan A, Prevec T, Vilfan G, Kocjan D, Copar A, Urleb U, Solmajer T.
    J Med Chem; 2007 Aug 23; 50(17):4113-21. PubMed ID: 17665896
    [Abstract] [Full Text] [Related]

  • 19. Cyclobutanone analogues of beta-lactams revisited: insights into conformational requirements for inhibition of serine- and metallo-beta-lactamases.
    Johnson JW, Gretes M, Goodfellow VJ, Marrone L, Heynen ML, Strynadka NC, Dmitrienko GI.
    J Am Chem Soc; 2010 Mar 03; 132(8):2558-60. PubMed ID: 20141132
    [Abstract] [Full Text] [Related]

  • 20. Hybrid QM/MM and DFT investigations of the catalytic mechanism and inhibition of the dinuclear zinc metallo-beta-lactamase CcrA from Bacteroides fragilis.
    Park H, Brothers EN, Merz KM.
    J Am Chem Soc; 2005 Mar 30; 127(12):4232-41. PubMed ID: 15783205
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.